Project Leader
Hidetaka Tanno
T cells play a critical role in adaptive immunity. They express an enormous repertoire of TCRs on their surfaces. Using these TCRs, T cells recognize antigen-HLA complexes presented by pathogenic cells and eliminate them. Therefore, elucidating the interactions between TCRs and antigen-HLA complexes will be useful for developing new therapeutics and preventive vaccines. For example, cancer-specific TCRs have shown promising results in recent clinical trials. However, it is still difficult to find useful antigen-specific TCRs. In our project, we are developing new technology that can identify TCR-antigen-HLA interactions in a high-throughput manner. By employing this technology, we are comprehensively analyzing cancer patients’ TCR-antigen-HLA repertoires to discover cancer-specific TCRs that can be used for T cell therapies. We will also apply this technology to elucidate the mechanisms of virus infections and autoimmune diseases.